- 4 recent hospital, health system CFO moves in 2026
- Oregon hospital aims to fast-track merger to ‘avoid insolvency’
- What happens to ASC contracts when a payer gets absorbed
- What will make or break the future of DSO success
- TriStar hospital taps new COO
- 24 large health systems growing bigger
- Why a shrinking US labor force matters for healthcare hiring
- 32 academic health systems acquiring hospitals
- Dentistry reaches inflection point with AI
- Baptist Health taps platform for AI hospital-at-home screening
- Former UPMC cardiologist drops suit over CEO’s device company ties
- Weill Cornell taps chief surgeon from UCLA
- IKS Health completes $557M TruBridge acquisition
- Dental assistant pay vs. cost of living by state
- The peptide boom: What healthcare leaders should know
- South Carolina cites behavioral health facility over missing correction plan
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- GI consolidation’s new era: 5 deals to know
- The GI procedure cuts in CMS’ pay proposal: 5 things to know
- ‘The economics just don’t work’: CMS’ ACCESS model draws scrutiny
- Washington restricts spit hood use in state psychiatric facilities
- Remarks at the Society for Corporate Governance Conference
- Maryland health system receives $10M gift to construct ASC
- 1-800-Dentist faces class-action lawsuit over data breach
- Staten Island hospital debuts mobile behavioral health program for youth
- A lifeline for the anesthesia workforce?
- Tennessee physician sentenced for reusing medical devices in $41M fraud scheme
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- Telehealth ex-CEO sentenced in Adderall fraud case: 5 things to know
- Oklahoma awards 4 behavioral health clinic contracts
- MidWest Eye Center taps ophthalmologist
- Why anesthesia groups are breaking up with private equity
- The key to patient trust in dentistry
- Good news, bad news for the dental workforce
- 7 behavioral health layoffs to know | 2026
- Inside this state’s crackdown on physician practice control
- 200+ dentists making headlines halfway through 2026
- How students are paying for dental school
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- U of Kentucky dental dean receives top educator award
- The dividing line between private practices and DSOs
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- 36 behavioral health executive moves to know
- Delaware establishes statewide opioid treatment guidance for EDs
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Catalent sells UK facility to Codis, expands Nanoscope partnership
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Nonprofit-private equity joint ventures worth scrutiny, PESP report says
- Lenz Therapeutics rolls out telehealth offering for Vizz prescription eye drops
- American Heart Association joins social network Roon for medical research collaboration
- Independent pharmacies hit Prime Therapeutics with antitrust suit over alleged price fixing
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Ascension plans to acquire independent system Williamson Health for nearly $1B
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Novartis dismisses 322 more staffers based out of US headquarters
- Allegheny Health Network acquires Heritage Valley Health System
- Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa
- FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
- Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
- Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub
- Skin quality driving widespread quality-of-life issues: survey
- AI care partner Heidi puts a spin on pharma ad tropes in new campaign to relieve 'side effects'
- AI care partner Heidi puts a spin on pharma ad tropes in new campaign to relieve 'side effects'
- Handspring Health lands $19M series B to expand behavioral health model for youth
- Nonprofit hospitals are embracing high-risk, high-reward investment portfolios. Is that a problem?
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Teladoc Health inks multi-year virtual care deal with National Basketball Players Association
- FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Regulatory tracker: AbbVie, Genmab's blood cancer bispecific expands label in EU
- Can A Popular Muscle Supplement Help Treat Depression?
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Remarks at the Economic Club of New York
- ‘Seeing the evolution’: As branded patent cliff looms, biosimilar experts size up US hurdles, opportunities ahead
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
Michigan healthcare freedom community forum
Dr. Joseph Varon, M.D. is a prominent critical care physician Houston, Texas. He has made significant contributions to the field of medicine, particularly during the COVID-19 pandemic. His current positions are:
- Chief of Staff at United Memorial Medical Center
- Chairman of the Board at United General Hospital
- President of the Independent Medical Alliance
- Professor of Acute and Continuing Care at the University of Texas Health Science Center in Houston
- Clinical Professor of Medicine at the University of Texas Medical Branch in Galveston
Dr. Varon takes exception to the muzzling of physicians which began during the COVID pandemic as public health officers ruthlessly stifled all medical challenges to politically approved treatments:
https://brownstone.org/articles/what-covid-policy-did-to-doctors-who-refused-to-stay-silent/
What Covid Policy Did to Doctors Who Refused to Stay Silent
By Joseph Varon - March 14, 2026The sound I remember most from the early days of Covid-19 is not the alarms. It was the silence between them. Intensive care units became Covid wards. Monitors glowed in dark rooms while ventilators pushed air into failing lungs. Nurses, shrouded in protective gear, moved quietly. Families were absent—barred from being with loved ones in their final hours.
One night at 3 am, I stood by a patient whose oxygen levels were steadily falling. Outside the room, another patient crashed. Down the hall, a third awaited intubation. For months, this was every night. For 715 consecutive days, I worked in that environment without taking a single day off. In moments like that, medicine becomes very simple. There are no politics in an ICU at 3 am. There is only a physician and a patient, and the responsibility to do everything possible to keep that patient alive.
That philosophy has guided physicians for generations. It is the foundation of clinical medicine: when a patient is dying, you explore every reasonable option that might help.
Yet during Covid, something extraordinary happened. What made the shift so jarring was not simply the presence of disagreement. Physicians have always disagreed. In fact, disagreement is the normal language of medicine. Grand rounds exist for that reason. Journal clubs exist for that reason. The entire structure of scientific publication—from peer review to replication—exists because medicine advances through argument, not obedience. During the pandemic, however, the culture of medicine changed almost overnight. Instead of asking whether a treatment might work, institutions began asking whether discussing that treatment might create the wrong public message. The priority quietly shifted from discovery to control.
Scientific debate faded. Physicians who questioned policies or explored treatments were treated as threats rather than colleagues. Instead of debate, there was enforcement.
Hospitals warned physicians to stay quiet. Medical boards hinted at disciplinary action. Social media platforms censored discussion of therapies that doctors around the world were actively studying. Media outlets portrayed dissenting physicians as reckless or dangerous. What had once been normal scientific discourse was suddenly labeled misinformation.
To physicians trained in earlier decades, this shift was deeply unsettling. Medicine has always lived with uncertainty. Treatments begin as hypotheses and evolve through observation and debate. During the AIDS crisis, clinicians tried multiple strategies before effective therapies emerged. The same was true for sepsis, trauma care, and organ transplantation. No one expected immediate unanimity. Yet during Covid, uncertainty itself became suspect. If a physician acknowledged that evidence was incomplete—or that clinical experience suggested alternative approaches—those statements were sometimes interpreted as challenges to authority rather than contributions to knowledge.
For those of us working inside the ICU, the shift was startling. Medicine had always thrived on disagreement. Physicians argued over treatment strategies, debated emerging evidence, and learned from one another’s experiences. The process was messy, sometimes loud, and occasionally uncomfortable—but it was also the engine of medical progress. During Covid, that process was replaced by something else entirely: the expectation of unanimity. I experienced this transformation firsthand.
During the pandemic, I spoke publicly about what I was seeing inside the ICU—what treatments appeared to help, what policies seemed ineffective, and why physicians needed the freedom to treat patients according to their clinical judgment.
Those comments triggered a reaction that made clear how medical freedom—a core value of our profession—had come under threat. Professional attacks followed, and colleagues were pressured to distance themselves. Invitations disappeared. Media narratives were constructed that bore little resemblance to the reality many of us were witnessing inside hospitals. But perhaps the most revealing response was silence.
Privately, many physicians admitted that the environment had become toxic for honest scientific discussion. In quiet conversations they would agree that open debate had been replaced by institutional pressure. Publicly, however, very few were willing to risk speaking. I chose not to remain silent.
That silence did not necessarily mean physicians agreed with what was happening. More often it meant they understood the risks of speaking. Hospitals depend on reputations. Universities depend on funding. Physicians depend on licenses. When the boundaries of acceptable opinion begin to narrow, most professionals instinctively step back. It is not cowardice; it is survival. But the cumulative effect of that silence is profound. When enough physicians remain quiet, the illusion of consensus begins to replace the reality of debate.
Over the course of the pandemic, I gave more than 4,000 television and media interviews, attempting to explain what physicians were seeing on the front lines and defending the principle that doctors must be allowed to think, question, and treat patients according to their best clinical judgment. The experience was both exhausting and illuminating. Again and again, I found myself explaining basic principles of medicine to audiences who had been told that questioning official policy was somehow dangerous.
Medicine has never advanced through silence. Every major breakthrough in medical history, from antibiotics to organ transplantation, began with physicians willing to challenge prevailing assumptions. Scientific progress depends on disagreement. It requires physicians to ask uncomfortable questions and explore possibilities that established authorities may initially reject. When debate is replaced by enforced consensus, science ceases to function.
That decision to speak carried consequences. Professionally and financially, the cost was substantial. The controversy surrounding Covid treatment debates resulted in lost opportunities, canceled collaborations, and significant professional retaliation. The economic impact was severe, resulting in roughly a 60 percent reduction in my income, a consequence that continues to this day.
Financial pressure has always been one of the most effective tools for enforcing conformity in any profession. Medicine is no exception. Physicians spend decades training, accumulate significant professional responsibilities, and depend on institutional relationships to practice. When controversy threatens those relationships, the safest option is often to say nothing. Many doctors understood this reality during Covid. Some quietly expressed agreement in private conversations but made clear they could not say so publicly. In that environment, silence became the profession’s default posture. For many physicians, that kind of pressure is enough to ensure silence. But the financial cost was never the hardest part.
What made the experience even more disturbing was watching what happened to colleagues who chose to speak openly. Some physicians lost hospital privileges almost overnight. Others faced medical board investigations triggered not by patient complaints, but by their public statements or willingness to question prevailing policies. Careers built over decades were suddenly placed under threat. A number of doctors saw research collaborations vanish, academic appointments quietly withdrawn, and professional reputations publicly attacked. The message became unmistakable: disagreement would carry consequences.
The personal toll was often even greater. Financial pressure, professional isolation, and relentless public scrutiny spilled into physicians’ private lives. I watched colleagues struggle as marriages fractured under the strain of media attacks, legal battles, and the sudden collapse of careers they had spent their lives building. Some left clinical practice entirely. Others retreated from public discussion simply to protect their families. The pandemic revealed something few physicians had previously experienced—the realization that speaking honestly about patient care could place not only one’s career at risk, but one’s personal life as well.
The hardest part was watching medicine surrender one of its most essential principles: the freedom to think and speak for patients. The pandemic response exposed how vulnerable modern medicine has become to political pressure, institutional fear, and media narratives. Decisions that should have remained within the realm of clinical judgment were increasingly dictated by bureaucratic authority.
In theory, medicine is guided by science. In practice, during Covid, it often appeared to be guided by messaging. That realization has prompted an important effort to document what happened during the pandemic and to ensure that physicians’ experiences are not erased from the historical record. One such effort is the COVID Justice initiative, which seeks to collect and document the stories of doctors, nurses, scientists, and patients affected by pandemic policies. The COVID Justice Resolution is an attempt to ensure that the suppression of scientific debate, the censorship of physicians, and the professional retaliation many experienced are openly acknowledged rather than quietly forgotten. The goal is not vengeance. It is accountability and transparency.
If the medical profession refuses to confront what happened during the pandemic—if it pretends that physicians were not pressured, censored, or punished—then the same mistakes will almost certainly be repeated during the next public health crisis.
History shows that institutions rarely correct themselves without accountability. On the front lines, many of us witnessed something deeply troubling: modern medicine’s increasing dependence on bureaucratic authority. When that authority collides with bedside care, physicians can find themselves forced to choose between professional safety and patient advocacy. Every doctor eventually faces that choice. During Covid, many of us faced it together. Some chose silence. Others chose to speak.
Speaking came with consequences. It costs reputations, careers, and, in many cases, substantial income. But the alternative—remaining silent while scientific debate was suppressed and physicians were discouraged from thinking independently—would have been a far greater betrayal of the profession.
Medicine cannot survive if doctors fear speaking freely and challenging consensus on behalf of their patients.
The next public health crisis will come. That is inevitable. When it does, the profession must remember what happened during Covid: how easily fear can replace reason, how quickly debate can be labeled dangerous, and how fragile scientific freedom becomes when institutions decide that certain questions are no longer allowed.
The real lesson of the pandemic is not about a virus. It is about the courage required to defend the integrity of medicine itself. Physicians must remain free to question, to debate, and to innovate in the service of their patients. Without that freedom, medicine becomes little more than bureaucratic compliance dressed in a white coat. And patients deserve far better than that. Because when physicians lose the freedom to question, patients lose something far more precious: the possibility that someone, somewhere, will be willing to challenge the rules in order to save their life.
That is the real price of speaking. The only question now is whether the medical profession still has the courage to pay it.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























